MAPT and Alzheimer disease: This is particularly evident in AD, in which the abnormal increases of the levels of amyloid-beta (Aβ) and Tau proteins and their aggregation are crucial steps in the chain of events leading to dementia (Irvine et al., 2008; Kopeikina et al., 2012).